Morton Brown Family Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-12
Closed -$1.1K 255
2023
Q1
$1.1K Buy
+12
New +$1.05K ﹤0.01% 257
2022
Q3
Sell
-80
Closed -$7K 303
2022
Q2
$7K Buy
+80
New +$7.02K 0.01% 126

Other funds holding NVS

Morton Brown Family Wealth's NVS Position: Q2 2023 in Review

Morton Brown Family Wealth sold out of Novartis (NVS) in Q2 2023, closing a stake of 12 shares — an estimated $1.1K sold.

Morton Brown Family Wealth first reported a position in NVS in Q2 2022 and held it in 2 quarters. The position peaked at $7K in Q2 2022. 1,202 funds tracked by Wall St. Rank hold NVS as of Q2 2023.

  • Morton Brown Family Wealth reported no remaining Novartis position as of Q2 2023 after selling out during the quarter.
  • Morton Brown Family Wealth sold 12 Novartis shares in Q2 2023, an estimated $1.1K.
  • Morton Brown Family Wealth first reported a position in Novartis in Q2 2022 and held it in 2 quarters.
  • Morton Brown Family Wealth's Novartis position peaked at $7K in Q2 2022.
  • 1,202 funds tracked by Wall St. Rank held Novartis as of Q2 2023.

Based on Morton Brown Family Wealth's 13F filing for Q2 2023, filed 25 Jul 2023.